Tokyo Lifestyle Co., Ltd. Reports First Six Months of Fiscal Year 2025 Financial Results
TOKYO, Dec. 18, 2024 /PRNewswire/ -- Tokyo Lifestyle Co., Ltd. ("Tokyo Lifestyle" or the "Company") (Nasdaq: TKLF), a retailer and...
Staff
Mentavi Health Expands Therapy Offerings to More Than 40 States
Doctorate-level psychologists will provide psychotherapy services, advancing Mentavi Health's mission of making high-quality care available to all via online mental...
Harris Data Integrity Solutions Taps Julie Pursley as Director of Industry Relations
NIAGARA FALLS, NY / ACCESSWIRE / December 18, 2024 / Harris Data Integrity Solutions, the leading provider of best-in-class person...
PharmPix Corp. Joins Forces With Mark Cuban Cost Plus Drug Company to Revolutionize Pharmacy Benefits
Revolutionizing Pharmacy Benefits: PharmPix and Cost Plus Drugs Partner to Deliver Unprecedented Medication Cost Transparency and Affordability DALLAS, TEXAS /...
Phase 2 Study Initiated to Evaluate Jaguar Health’s Crofelemer for Microvillus Inclusion Disease (MVID), an Ultrarare Congenital Diarrheal Disorder
The study is one of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies -...
2025 Mobile EHR Global Report: Advancing Cloud-Based Digital Health Records in Europe. Africa and the Middle East – Black Book Research
Black Book unveils its 2025 global survey on mobile electronic health records, showcasing how non-U.S. nations are leveraging innovative platforms...
Verisante Technology, Inc. Announces RTO Update:
RTO Partner SunRegen Healthcare AG Closes Private Placement for $2.1 Million VANCOUVER, BC / ACCESSWIRE / December 18, 2024 /...
CordovaCann (CSE:CDVA)(OTCQB:LVRLF) Provides Year-End Update On Star Buds Cannabis Co. Retail Operations
Star Buds Cannabis Co. Stores Close Out 2024 On a High Note TORONTO, ON / ACCESSWIRE / December 18, 2024...
Lexaria Forms New Scientific Advisory Board
North American drug delivery development experts added to help guide Lexaria's strategic plans KELOWNA, BC / ACCESSWIRE / December 18,...
Awakn Life Sciences Announces Credit Facility
Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or...
Awakn Life Sciences Announces Credit Facility
Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or...
NeoPredics Welcomes Todd Usen as Chairman of the Board
FORT LAUDERDALE, FLORIDA / ACCESSWIRE / December 18, 2024 / NeoPredics AG Switzerland, along with its subsidiaries NeoPredics AG Germany...
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
- Regulatory Approval Showcases Clinical Advancement of Linea DNA™ as a Rapid and Effective Means of Producing CAR-T cell Therapies...
The Naderi Center for Plastic Surgery and Dermatology Reveals Updated Website for Virginia and Maryland Patients
The Naderi Center's website upgrade offers comprehensive procedure insights and booking. RESTON, VIRGINIA / ACCESSWIRE / December 18, 2024 /...
CBD Life Sciences Inc. (CBDL) Announces 3.5 Billion Share Reduction From the Authorization
Demonstrating shareholder confidence, CBDL commits to repurchasing 10% of revenue quarterly. SCOTTSDALE, AZ / ACCESSWIRE / December 18, 2024 /...
Interactive Strength Inc. (Nasdaq:TRNR) Secures 162 Unit CLMBR Commitment and Signs Exclusive Distribution Agreement With Planet Fitness SAS for France
Three-Year Agreement Expected to Generate more than $0.5million in Revenue, and Covers France and French RegionsFrance is the Second-Largest Fitness...
Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA
From giving AI the sense of smell and breakthrough in rare disease treatments, Ainos is shaping 2025 with bold technologies...
Braille Institute Library to Host Livestream Event with Pulitzer Prize Finalist Andrew Leland on January 16, 2025
Leland to discuss his best-selling book, “The Country of the Blind: A Memoir at the End of Sight” LOS ANGELES,...
BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions
Collaboration will leverage BioAge's differentiated human longevity data and platform and Novartis expertise in the biology of physical exercise to...
Rafarma pharmaceutical updates
Sheridan, Wyoming, USA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) Dear Rafarma shareholders, We apologize for the...